Silvercrest Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $13.5M | Buy |
|
|||||
|
2025
Q3 | $7.44M | Sell |
|
|||||
|
2025
Q2 | $5.55M | Buy |
|
|||||
|
2025
Q1 | $4.36M | Sell |
|
|||||
|
2024
Q4 | $5.04M | Sell |
|
|||||
|
2024
Q3 | $5.74M | Sell |
|
|||||
|
2024
Q2 | $5.36M | Buy |
|
|||||
|
2024
Q1 | $4.42M | Buy |
|
|||||
|
2023
Q4 | $5.09M | Sell |
|
|||||
|
2023
Q3 | $4.37M | Buy |
|
|||||
|
2023
Q2 | $3.52M | Buy |
|
|||||
|
2023
Q1 | $2.65M | Sell |
|
|||||
|
2022
Q4 | $2.92M | Sell |
|
|||||
|
2022
Q3 | $4.37M | Sell |
|
|||||
|
2022
Q2 | $4.61M | Sell |
|
|||||
|
2022
Q1 | $4.27M | Buy |
|
|||||
|
2021
Q4 | $5.16M | Buy |
|
|||||
|
2021
Q3 | $4.25M | Sell |
|
|||||
|
2021
Q2 | $4.37M | Buy |
|
|||||
|
2021
Q1 | $3.02M | Buy |
|
|||||
|
2020
Q4 | $4.02M | Sell |
|
|||||
|
2020
Q3 | $2.85M | Sell |
|
|||||
|
2020
Q2 | $3.1M | Buy |
|